In the last year, many Merck & Co., Inc. ( NYSE:MRK ) insiders sold a substantial stake in the company which may ...

The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.

MilliporeSigma, the North American drug services arm of Merck KGaA, says it will invest $76 million to ... The process takes ...

Global investors are eyeing fresh opportunities in China as the world’s second-largest economy accelerates its intelligent, ...

SHANGHAI: Global investors are eyeing fresh opportunities in China as the world's second-largest economy accelerates its ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Prostate cancer has proved an elusive target for cancer immunotherapies, and Merck & Co's checkpoint inhibitor Keytruda is the latest to fall short in the disease in a phase 3 trial. Merck has ...

Cadence’s Satish Kumar C explores how the Deferrable Memory Write transaction type in PCIe and CXL can improve latency, ...

November 6, 2024Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.33.